An advanced human heart organoid system can be used to model embryonic heart development under pregestational diabetes-like conditions, researchers report. The organoids recapitulate hallmarks of ...

Having explored how the heart is formed in utero, a researcher is reporting how cells and molecules act during that early formation and what might cause the heart disease called left ventricular ...

Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists – so far. A new multi-chamber organoid ...

Tenaya Therapeutics (TNYA) is a very interesting biotech because it is in the process of developing two one-time gene therapies to treat patients with common genetic heart disorders. I believe that ...

In a study involving data from thousands of people, the risk of a new coronary heart disease diagnosis was statistically ...

Using a combination for spatial, single-cell transcriptomics and imaging data from 36 hearts, scientists from the KTH Royal Institute of Technology and their collaborators have come up with what they ...

The new guidelines aim to give doctors and their patients an individualized and clear path to follow. Heart disease remains ...

Rheumatic heart disease is a serious complication of Group A Streptococcus infection. It can cause damage to the valves in your heart and may cause severe heart problems in the future. Rheumatic heart ...